Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan-Mar;8(1):31-36.
doi: 10.4103/2229-3485.198552.

Investigators' viewpoint of clinical trials in India: Past, present and future

Mohandas K Mallath  1 , Tanuj Chawla  2
Affiliations
Review

Investigators' viewpoint of clinical trials in India: Past, present and future

Mohandas K Mallath et al. Perspect Clin Res. 2017 Jan-Mar.

Abstract

India's success in producing food and milk for its population (Green Revolution and White Revolution) happened because of scientific research and field trials. Likewise improving the health of Indians needs clinical research and clinical trials. A Large proportion of the sick Indians are poor, illiterate with no access to good health care. They are highly vulnerable to inducement and exploitation in clinical trials. The past two decades saw the rise and fall of clinical trials in India. The rise happened when our regulators created a favorable environment, and Indian investigators were invited to participate in global clinical trials. The gap between the demand and supply resulted in inadequate protection of the trial participants. Reports of abuses of the vulnerable trial participants followed by public interest litigations led to strengthening of regulations by the regulators. The stringent new regulations made the conduct of clinical trials more laborious and increased the cost of clinical trials in India. There was a loss of interest in sponsored clinical trials resulting in the fall in global clinical trials in India. Following repeated appeals by the investigators, the Indian regulators have recently relaxed some of the stringent regulations, while continuing to ensure the adequate patient protection. Clinical trials that are relevant to our population and conducted by well-trained investigators and monitored by trained and registered Ethics Committees will increase in the future. We must remain vigilant, avoid previous mistakes, and strive hard to protect the trial participants in the future trials.

Keywords: Compensation; Ethics Committee; informed consent; investigator; patient protection.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Census of India 2011, Population Enumeration Data (Final Population) [Last accessed on 2016 Nov 08]. Available from: http://www.censusindia.gov.in/2011census/population_enumeration.html.
    1. Sample Registration System – Presentation on Causes of Deaths in India – 2010-2013. [Last accessed on 2016 Nov 19]. Available from: http://www.censusindia.gov.in/2011-Common/Sample_Registration_System.html.
    1. Christie DA, Tansey EM, editors. Short-Course Chemotherapy for Tuberculosis, Wellcome Witnesses to Twentieth Century Medicine. Vol. 24. London: Wellcome Trust Centre for the History of Medicine at UCL; 2005.
    1. Blane G. Account of the epidemic spasmodic cholera, which has lately prevailed in India, and other adjacent countries and Islands, and at sea. Communicated in a letter from Frederick Corbyn, Esq. Assistant surgeon on the Bengal Establishment. With communications on the same subject, by favor of the chairman and deputy chairman of the East India Company; and from the Islands of Mauritius and Ceylon, by favor of the medical board of the army. With remarks. Med Chir Trans. 1821;11(Pt 1):110–56. - PMC - PubMed
    1. Rogers L. Further experience in forecasting epidemics of smallpox, plague, and cholera in India, and its bearing on the reduction of cholera. Proc R Soc Med. 1930;23:793–802. - PMC - PubMed